THE BEST SIDE OF SITUS JUDI MBL77

Not all sufferers with CLL demand therapy. Regardless of all latest advancements, the iwCLL however endorses watchful observation for clients with asymptomatic disorder.86 This recommendation is based on no less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)